Ventas Inc. Stock
Price
Target price
€69.10
€69.10
1.110%
0.76
1.110%
€68.46
04.12.25 / Tradegate
WKN: 878380 / Symbol: VTR / Name: Ventas / Stock / Residential & Commercial REIT / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Ventas Inc. Stock
Ventas Inc. gained 1.110% today.
We see a rather positive sentiment for Ventas Inc. with 17 Buy predictions and 1 Sell predictions.
However, we have a potential of -1.59% for Ventas Inc. as the target price of 68 € is below the current price of 69.1 €.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Ventas Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Ventas Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ventas Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ventas Inc. | 1.110% | 0.612% | 5.852% | 16.920% | 23.614% | 57.403% | 71.891% |
| Extra Space Storage | -0.310% | -3.091% | -3.886% | -28.008% | -20.443% | -25.582% | 20.978% |
| Welltower Inc | 0.140% | -2.256% | 8.102% | 40.024% | 47.810% | 162.100% | 231.413% |
| Healthpeak Properties Inc. | -0.680% | -6.962% | -5.769% | -27.941% | -23.037% | -39.256% | -41.736% |
Comments
Ventas (NYSE:VTR) had its price target raised by analysts at Wells Fargo & Company from $80.00 to $88.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) had its price target raised by analysts at Citigroup Inc. from $80.00 to $88.00. They now have a "buy" rating on the stock.
Show more
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) had its price target raised by analysts at Cantor Fitzgerald from $77.00 to $85.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for VTR provided by MarketBeat
News
Prediction: These Could Be the Best-Performing Healthcare Dividend Stocks Through 2030
There are times when unexpected global events have an outsized impact on a company's business. That was true across a broad spectrum of stocks after the coronavirus pandemic began. But at the center
3 Unstoppable Ultra-High-Yield Stocks to Buy Right Now for Less Than $500
The S&P 500 index (SNPINDEX: ^GSPC) has a miserly dividend yield of just 1.2% today. The average healthcare stock has a yield of just under 1.8%. But what if you could get yields from healthcare
Ventas Announces Second Quarter 2025 Earnings Release Date and Conference Call
Ventas, Inc. (NYSE: VTR) will issue its second quarter 2025 earnings release after the close of trading on the New York Stock Exchange on Wednesday, July 30, 2025. A conference call to discuss
